Australia has a notable opportunity in biotechnology, with ribonucleic acid (RNA) therapies and technologies primarily in the research phase, focusing on vaccines, protein therapies, cancer treatment and biopesticides.
Through research and consultation with multi-disciplinary experts, this report has identified the key challenges and opportunities for Australia to improve prevention, detection, diagnosis, and response to drug-resistant infections and reduce the impacts of antimicrobial resistance.
Read how Priming Grants enabled Australian researchers to meet and exchange ideas with colleagues in the Netherlands, the USA, China, Germany, Singapore and Japan to develop Medical Technologies and Pharmaceuticals ideas with collaborators there.
The Australian Academy of Technological Sciences and Engineering (ATSE) welcomes the opportunity to provide its response to the Terms of Reference for the inquiry into the role of smart ICT in the design and planning of infrastructure.